Ekaterina Berishvili - Switzerland
Dr. Berishvili is a trained surgeon with a PhD degree. Currently, she leads the Tissue Engineering and Organ Regeneration group at the University of Geneva and serves as the Head of the Cell Isolation and Transplantation Center at the University Hospitals of Geneva.
Her research focuses on developing advanced therapeutic medicinal products for curing type 1 diabetes by combining cell therapy and tissue bioengineering to create bio-artificial organs, specifically the endocrine pancreas. She has been awarded numerous competitive grants from European, US, and Swiss funding agencies.
Nationally, Dr. Berishvili serves as a member of the Swiss Transplant Cohort Study's scientific committee, the Geneva representative in the Swisstransplant working group for pancreas, islet, and small bowel transplantation (STAPS), and is a member of the Faculty Diabetes Center of UNIGE School of Medicine.
Dr. Berishvili is a councilor of the European Society of Transplantation (ESOT), a member of the JDRF Beta Cell Replacement Consortium, and has participated in several scientific program committees, including for the upcoming 2023 ESOT Congress. She serves as an associate editor of Transplant International.